Rimonabant: New therapeutic option for managing cardiometabolic risk

Unmet needs in obesity and the metabolic syndrome. Obesity, metabolic syndrome, and diabetes have reached epidemic proportions Increased prevalence of these conditions is projected to have a major impact on CV disease and associated costs of careEven modest weight loss (5%) can reduce cardiom

rosalyn + Follow